Farallon Capital Management, L.L.C. UK Regulatory Announcement: Form 8.3 – Horizon Therapeutics Plc
SAN FRANCISCO--(BUSINESS WIRE)-- FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Farallon Capital Management, L.L.C. on behalf…
